Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample. GlobalData's Medical Devices sector report, “Auto-Immune Diseases Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Auto-Immune Diseases Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Auto-Immune Diseases Diagnostic Tests Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Auto-Immune Diseases Diagnostic Tests pipeline products.
Review of Recent Developments in the segment / industry
The Auto-Immune Diseases Diagnostic Tests Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
'
Table of Contents
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Auto-Immune Diseases Overview 18
3 Products under Development 19
3.1 Auto-Immune Diseases – Pipeline Products by Stage of Development 19
3.2 Auto-Immune Diseases – Pipeline Products by Territory 20
3.3 Auto-Immune Diseases – Pipeline Products by Regulatory Path 21
3.4 Auto-Immune Diseases – Pipeline Products by Estimated Approval Date 22
3.5 Auto-Immune Diseases – Ongoing Clinical Trials 23
4 Auto-Immune Diseases – Pipeline Products under Development by Companies 24
4.1 Auto-Immune Diseases Companies – Pipeline Products by Stage of Development 24
4.2 Auto-Immune Diseases – Pipeline Products by Stage of Development 27
5 Auto-Immune Diseases Companies and Product Overview 33
5.1 Aarhus University Company Overview 33
5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview 33
5.2 Adaptive Biotechnologies Corp Company Overview 35
5.2.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Albert Ludwigs University of Freiburg Company Overview 36
5.3.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Alere Inc Company Overview 38
5.4.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 Amarantus Diagnostics Inc Company Overview 40
5.5.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 apDia nv Company Overview 42
5.6.1 apDia nv Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Autoimmune Technologies LLC Company Overview 43
5.7.1 Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Beckman Coulter Inc Company Overview 47
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.9 Bellvitge Biomedical Research Institute Company Overview 48
5.9.1 Bellvitge Biomedical Research Institute Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 BG Medicine Inc Company Overview 49
5.10.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.11 Biogen Inc Company Overview 50
5.11.1 Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 BIOHOPE Scientific SL Company Overview 51
5.12.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 Biomedal SL Company Overview 53
Contd…
5.13.1 Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Bionure Farma SL Company Overview 56
5.14.1 Bionure Farma SL Pipeline Products & Ongoing Clinical Trials Overview 56
5.15 CDI Laboratories Inc Company Overview 57
5.15.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Celdara Medical LLC Company Overview 58
5.16.1 Celdara Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 Charite University Hospital of Berlin Company Overview 59
5.17.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 59
5.18 Chronix Biomedical Inc Company Overview 60
5.18.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.19 Cincinnati Children's Hospital Medical Center Company Overview 62
5.19.1 Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Columbia University Company Overview 63
5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 63
5.21 Crescendo Bioscience Inc Company Overview 64
5.21.1 Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.22 Digna Biotech SL Company Overview 67
5.22.1 Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 67
5.23 DNAlytics SA Company Overview 69
5.23.1 DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview 69
5.24 Enterome Bioscience SA Company Overview 72
5.24.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 72
5.25 Exodus Biosciences LLC Company Overview 74
5.25.1 Exodus Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview 74
5.26 Ezose Sciences Inc. Company Overview 75
5.26.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.27 Flamentera AG Company Overview 76
5.27.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 76
5.28 Genalyte Inc Company Overview 77
5.28.1 Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.29 GeNeuro SA Company Overview 78
5.29.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 Grifols SA Company Overview 79
5.30.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Hannover Medical School Company Overview 80
5.31.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 HealthTell Inc Company Overview 81
5.32.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.33 Helmholtz Centre for Infection Research Company Overview 87
5.33.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 87
5.34 HOB Biotech Group Suzhou Co Ltd Company Overview 88
5.34.1 HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
5.35 Hospital for Special Surgery Company Overview 89
5.35.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 89
5.36 Hycor Biomedical Inc Company Overview 90
5.36.1 Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 90
5.37 Ignyta Inc Company Overview 92
5.37.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 92
5.38 Immunarray Pvt Ltd Company Overview 94
5.38.1 Immunarray Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.39 Immunodiagnostic Systems Holdings plc Company Overview 95
5.39.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Immunovia AB Company Overview 96
5.40.1 Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 ImmusanT Inc Company Overview 100
5.41.1 ImmusanT Inc Pipeline Products & Ongoing Clinical Trials Overview 100
5.42 Innobiochips Company Overview 102
5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 102
5.43 Inova Diagnostics Inc Company Overview 103
5.43.1 Inova Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 103
5.44 IPDx Immunoprofiling Diagnostics GmbH Company Overview 108
5.44.1 IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 108
5.45 Iquity Labs Inc Company Overview 109
5.45.1 Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 109
5.46 Iron Horse Diagnostics, Inc. Company Overview 110
5.46.1 Iron Horse Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.47 Johns Hopkins University Company Overview 112
5.47.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 112
5.48 Lankenau Institute for Medical Research Company Overview 114
5.48.1 Lankenau Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 114
5.49 LineaGen Inc Company Overview 115
5.49.1 LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 115
5.50 Lophius Biosciences GmbH Company Overview 116
5.50.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 116
5.51 Louisville Bioscience Inc (Inactive) Company Overview 117
5.51.1 Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 117
5.52 Max Delbruck Center for Molecular Medicine Company Overview 120
5.52.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 120
5.53 Medica Corp Company Overview 121
5.53.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 121
5.54 Medical & Biological Laboratories Co Ltd Company Overview 124
5.54.1 Medical & Biological Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Metabiomics Corporation Company Overview 125
5.55.1 Metabiomics Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.56 Metabolomic Technologies Inc Company Overview 128
5.57 Metanomics Health GmbH Company Overview 131
5.57.1 ics Health G5.57 Metanomics Health GmbH Company Overview 131
5.57.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 131
5.58 MSDx Inc Company Overview 132
5.58.1 MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview 132
5.59 Myriad Genetics Inc Company Overview 133
5.59.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133
5.60 Nanosphere Inc Company Overview 134
5.60.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.61 Neuro Vigor LLC Company Overview 135
5.61.1 Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview 135
5.62 Northwestern University Company Overview 136
5.62.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 136
5.63 NoToPharm srl Company Overview 137
5.63.1 NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview 137
5.64 Numares AG Company Overview 143
5.64.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview 143
5.65 OmniBiome Therapeutics Inc Company Overview 144
5.65.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 144
5.66 One Way Liver SL Company Overview 145
5.66.1 One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.67 OPKO Health Inc Company Overview 146
5.67.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.68 Op-T-Mune Inc Company Overview 147
5.68.1 Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.69 Oxford Gene Technology Ltd Company Overview 148
5.69.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
5.70 Oxford Immunotec Ltd Company Overview 149
5.70.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview 149
5.71 Pediatric Bioscience LLC Company Overview 150
5.71.1 Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview 150
5.72 Penn State College of Medicine Company Overview 151
5.72.1 Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 151
5.73 ProciseDx LLC Company Overview 152
5.73.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 152
5.74 Progentec Diagnostics Inc Company Overview 153
5.74.1 Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 153
5.75 Protagen AG Company Overview 158
5.75.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 158
5.76 ProteinLogic Ltd Company Overview 163
5.76.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 163
5.77 Quanterix Corp Company Overview 164
5.77.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 164
5.78 Rambam Health Care Campus Company Overview 165
5.78.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 165
5.79 Rappaport Family Institute for Research in the Medical Science Company Overview 166
5.79.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview 166
5.80 Regulus Therapeutics Inc Company Overview 167
5.80.1 Regulus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 167
5.81 Roche Diagnostics International Ltd Company Overview 168mbH Pipeline Products & Ongoing Clinical Trials Overview 131
5.58 MSDx Inc Company Overview 132
5.58.1 MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview 132
5.59 Myriad Genetics Inc Company Overview 133
5.59.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133
5.60 Nanosphere Inc Company Overview 134
5.60.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.61 Neuro Vigor LLC Company Overview 135
5.61.1 Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview 135
5.62 Northwestern University Company Overview 136
5.62.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 136
5.63 NoToPharm srl Company Overview 137
5.63.1 NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview 137
5.64 Numares AG Company Overview 143
5.64.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview 143
5.65 OmniBiome Therapeutics Inc Company Overview 144
5.65.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 144
5.66 One Way Liver SL Company Overview 145
5.66.1 One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.67 OPKO Health Inc Company Overview 146
5.67.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.68 Op-T-Mune Inc Company Overview 147
5.68.1 Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.69 Oxford Gene Technology Ltd Company Overview 148
5.69.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
5.70 Oxford Immunotec Ltd Company Overview 149
5.70.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview 149
5.71 Pediatric Bioscience LLC Company Overview 150
5.71.1 Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview 150
5.72 Penn State College of Medicine Company Overview 151
5.72.1 Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 151
5.73 ProciseDx LLC Company Overview 152
5.73.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 152
5.74 Progentec Diagnostics Inc Company Overview 153
5.74.1 Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 153
5.75 Protagen AG Company Overview 158
5.75.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 158
5.76 ProteinLogic Ltd Company Overview 163
5.76.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 163
5.77 Quanterix Corp Company Overview 164
5.77.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 164
5.78 Rambam Health Care Campus Company Overview 165
5.78.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 165
5.79 Rappaport Family Institute for Research in the Medical Science Company Overview 166
5.79.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview 166
5.80 Regulus Therapeutics Inc Company Overview 167
5.80.1 Regulus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 167
5.81 Roche Diagnostics International Ltd Company Overview 168
5.56.1 Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 128
5.57 Metanomics Health GmbH Company Overview 131
5.57.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 131
5.58 MSDx Inc Company Overview 132
5.58.1 MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview 132
5.59 Myriad Genetics Inc Company Overview 133
5.59.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133
5.60 Nanosphere Inc Company Overview 134
5.60.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.61 Neuro Vigor LLC Company Overview 135
5.61.1 Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview 135
5.62 Northwestern University Company Overview 136
5.62.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 136
5.63 NoToPharm srl Company Overview 137
5.63.1 NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview 137
5.64 Numares AG Company Overview 143
5.64.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview 143
5.65 OmniBiome Therapeutics Inc Company Overview 144
5.65.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 144
5.66 One Way Liver SL Company Overview 145
5.66.1 One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.67 OPKO Health Inc Company Overview 146
5.67.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.68 Op-T-Mune Inc Company Overview 147
5.68.1 Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.69 Oxford Gene Technology Ltd Company Overview 148
5.69.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
5.70 Oxford Immunotec Ltd Company Overview 149
5.70.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview 149
5.71 Pediatric Bioscience LLC Company Overview 150
5.71.1 Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview 150
5.72 Penn State College of Medicine Company Overview 151
5.72.1 Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 151
5.73 ProciseDx LLC Company Overview 152
5.73.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 152
5.74 Progentec Diagnostics Inc Company Overview 153
5.74.1 Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 153
5.75 Protagen AG Company Overview 158
5.75.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 158
5.76 ProteinLogic Ltd Company Overview 163
5.76.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 163
5.77 Quanterix Corp Company Overview 164
5.77.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 164
5.78 Rambam Health Care Campus Company Overview 165
5.78.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 165
5.79 Rappaport Family Institute for Research in the Medical Science Company Overview 166
5.79.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview 166
5.80 Regulus Therapeutics Inc Company Overview 167
5.80.1 Regulus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 167
5.81 Roche Diagnostics International Ltd Company Overview 168
5.81.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 168
5.82 Seattle Children's Hospital Company Overview 171
5.82.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 171
5.83 Sengenics Corp Pte Ltd Company Overview 172
5.83.1 Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 172
5.84 Sequenom Inc Company Overview 176
5.84.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 176
5.85 Shuwen Biotech Co Ltd Company Overview 177
5.85.1 Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 177
5.86 SomaLogic Inc Company Overview 178
5.86.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 178
5.87 Southern Illinois University Carbondale Company Overview 179
5.87.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 179
5.88 SQI Diagnostics Inc Company Overview 181
5.88.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 181
5.89 Statens Serum Institut Company Overview 186
5.89.1 Statens Serum Institut Pipeline Products & Ongoing Clinical Trials Overview 186
5.90 Svar Life Science AB Company Overview 187
5.90.1 Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview 187
5.91 TBG Diagnostics Ltd Company Overview 188
5.91.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 188
5.92 The University of Manchester Company Overview 189
5.92.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 189
5.93 The Walter and Eliza Hall Institute of Medical Research Company Overview 191
5.93.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 191
5.94 Toscana Biomarkers Srl Company Overview 192
5.94.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 192
5.95 University Health Network Company Overview 196
5.95.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 196
5.96 University of Alberta Company Overview 197
5.96.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 197
5.97 University of California San Francisco Company Overview 198
5.97.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 198
5.98 University of Chicago Company Overview 200
5.98.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 200
5.99 University of Colorado Company Overview 201
5.99.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 201
5.100 University of Illinois at Chicago Company Overview 202
5.100.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 202
5.101 University of Maryland Baltimore Company Overview 203
5.101.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 203
5.102 University of Missouri Company Overview 204
5.102.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 204
5.103 University of Oslo Company Overview 205
5.103.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview 205
5.104 University of Oxford Company Overview 206
5.104.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 206
5.105 University of Pecs Company Overview 208
5.105.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 208
5.106 University of Southern California Company Overview 209
5.106.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 209
5.107 University Rovira i Virgili Company Overview 210
5.107.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 210
5.108 US Biomarkers Inc Company Overview 211
5.108.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 211
5.109 Washington University in St Louis Company Overview 212
5.109.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 212
5.110 XEPTAGEN SpA Company Overview 213
5.110.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 213
5.111 Yale University Company Overview 214
5.111.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 214
6 Auto-Immune Diseases- Recent Developments 215
6.1 Aug 04, 2020: Oxford Immunotec reports second quarter 2020 financial results 215
6.2 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 216
6.3 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 216
6.4 Jun 04, 2020: Alpine Immune Sciences presents preclinical data on novel dual BAFF/APRIL inhibitory domains for B cell mediated autoimmune diseases at the European Congress of Rheumatology E-Congress 2020 217
6.5 Jun 02, 2020: EGFR biology, inhibitors & ADCC 217
6.6 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology 218
6.7 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting 219
6.8 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services 220
6.9 May 12, 2020: CHDR announces addition of premises with supplementary office space in the Leiden Bio Science Park! 220
6.10 Mar 09, 2020: Exagen partners with three California medical groups to offer AVISE testing as covered in-network benefit for their patients 220
6.11 Mar 02, 2020: Neon Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 221
6.12 Feb 27, 2020: Grifols reaches revenue of EUR 5,100 million, a
13.6% increase, and raises its profits to EUR 625 million 222
6.13 Feb 27, 2020: CareDx reports fourth quarter and full year 2019 results 228
6.14 Feb 27, 2020: SQI Diagnostics reports first quarter 2020 results 229
6.15 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 232
6.16 Feb 26, 2020: Adaptive Biotechnologies reports fourth quarter and full year 2019 financial results 233
6.17 Feb 14, 2020: Immunovia full year report 2019 234
6.18 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results 234
6.19 Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results 236
6.20 Feb 06, 2020: Myriad announces leadership transition 237
6.21 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results 238
6.22 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users 240
6.23 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 240
6.24 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 242
6.25 Jan 30, 2020: The Crown Princess of Sweden and Prince Daniel visited Immunovia in Lund 245
6.26 Jan 30, 2020: Theradiag reports 2019 revenue of €9.6 million, Up
8.3% 245
6.27 Jan 30, 2020: OGT launches breakthrough NGS panel for constitutional cytogenetics 247
6.28 Jan 21, 2020: Adaptive announces preliminary unaudited revenue for full year 2019 248
6.29 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology 248
6.30 Jan 13, 2020: Immunovia strengthen management with new senior VP of Sales North America ahead of the IMMray PanCan-d Test launch 249
6.31 Jan 13, 2020: CareDx reports preliminary fourth quarter and full year 2019 results 250
6.32 Jan 08, 2020: CareDx's false advertising complaint upheld by court 250
6.33 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President 251
6.34 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 251
6.35 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation 252
6.36 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents 252
6.37 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack 253
6.38 Dec 11, 2019: SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes 253
6.39 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 256
6.40 Nov 22, 2019: Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management 257
6.41 Nov 15, 2019: QIAGEN receives several conditional, non-binding indications of interest, enters into discussions to explore potential strategic alternatives 257
6.42 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 257
6.43 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 258
6.44 Nov 12, 2019: Neon Therapeutics reports third quarter 2019 financial results and recent highlights 258
6.45 Nov 12, 2019: Regulus Therapeutics reports third quarter 2019 financial results and recent updates 260
6.46 Nov 12, 2019: Adaptive Biotechnologies reports third quarter 2019 financial results 261
6.47 Nov 12, 2019: OGT continues move into molecular diagnostics markets 262
6.48 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 263
6.49 Nov 05, 2019: Oxford Immunotec reports third quarter 2019 financial results 264
6.50 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 265
7 Appendix 267
7.1 Methodology 267
7.2 About GlobalData 271
7.3 Contact Us 271
